-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LCtuDw3RoRIcY8zionVKOatxhi9vLKQnybDPufa9Q+08HPLmbRA0dCsv2GmiM0s3 D9br7heRaHV14Qn1WJwPcA== 0000950137-01-000516.txt : 20010209 0000950137-01-000516.hdr.sgml : 20010209 ACCESSION NUMBER: 0000950137-01-000516 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20010208 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NORTHFIELD LABORATORIES INC /DE/ CENTRAL INDEX KEY: 0000920947 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 363378733 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-44875 FILM NUMBER: 1528967 BUSINESS ADDRESS: STREET 1: 1560 SHERMAN AVE STREET 2: SUITE 1000 CITY: EVANSTON STATE: IL ZIP: 60201-4800 BUSINESS PHONE: 8478643500 MAIL ADDRESS: STREET 1: 1560 SHERMAN AVE STE 1000 STREET 2: 37TH FLOOR CITY: EVANSTON STATE: IL ZIP: 60201-4800 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: DEWOSKIN RICHARD E CENTRAL INDEX KEY: 0000938636 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: C/O NORTHFIELD LABORATORIES INC STREET 2: 1560 SHERMAN AVE. #1000 CITY: EVANSTON STATE: IL ZIP: 60201 BUSINESS PHONE: 8478643500 MAIL ADDRESS: STREET 1: C/O NORTHFIELD LABORATORIES INC STREET 2: 1560 SHERMAN AVE. #1000 CITY: EVANSTON STATE: IL ZIP: 60201 SC 13G/A 1 c59894a1sc13ga.txt AMENDMENT #1 TO SCHEDULE 13G 1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ---------------- SCHEDULE 13G (RULE 13D-102) Information to be Included in Statements Filed Pursuant to Rules 13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to Rule 13D-2(b) (AMENDMENT NO. 1) NORTHFIELD LABORATORIES INC. - -------------------------------------------------------------------------------- (Name of Issuer) COMMON STOCK, PAR VALUE $.01 PER SHARE - -------------------------------------------------------------------------------- (Title of Class of Security) 666135108 - -------------------------------------------------------------------------------- (CUSIP Number) DECEMBER 31, 2000 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [X] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes). 2 CUSIP No. 666135108 13G Page 2 of 6 Pages - -------------------------------------------------------------------------------- 1 Names of Reporting Persons/I.R.S. Identification Nos. of Above Persons (Entities Only) Richard E. DeWoskin - -------------------------------------------------------------------------------- 2 Check the Appropriate Box if a Member of a Group (a) [ ] (See Instructions) (b) [ ] - -------------------------------------------------------------------------------- 3 SEC Use Only - -------------------------------------------------------------------------------- 4 Citizenship or Place of Organization United States - -------------------------------------------------------------------------------- Number of 5 Sole Voting Power Shares 717,715 ----------------------------------------------------- Beneficially 6 Shared Voting Power -0- Owned by ----------------------------------------------------- 7 Sole Dispositive Power Each 717,715 ----------------------------------------------------- Reporting 8 Shared Dispositive Power Person With -0- - -------------------------------------------------------------------------------- 9 Aggregate Amount Beneficially Owned by Each Reporting Person 717,715 - -------------------------------------------------------------------------------- 10 Check if the Aggregate Amount in Row (9) Excludes Certain Shares [ ] (See Instructions) - -------------------------------------------------------------------------------- 11 Percent of Class Represented by Amount in Row (9) 5.0% - -------------------------------------------------------------------------------- 12 Type of Reporting Person (See Instructions) IN - -------------------------------------------------------------------------------- 3 ITEM 1(A). NAME OF ISSUER. Northfield Laboratories Inc. ITEM 1(B). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES. 1560 Sherman Avenue Suite 1000 Evanston, Illinois 60201-4800 ITEM 2(A). NAME OF PERSON FILING. Richard E. DeWoskin ITEM 2(B). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE. c/o Northfield Laboratories Inc. 1560 Sherman Avenue Suite 1000 Evanston, Illinois 60201-4800 ITEM 2(C). CITIZENSHIP. United States. ITEM 2(D). TITLE OF CLASS OF SECURITIES. Common Stock, par value $.01 per share. ITEM 2(E). CUSIP NUMBER. 666135108 Page 3 of 6 Pages 4 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B), OR 13D-2(B) OR (C), CHECK WHETHER THE PERSON FILING IS A: (a) [ ] Broker or dealer registered under Section 15 of the Exchange Act. (b) [ ] Bank as defined in Section 3(a)(6) of the Exchange Act. (c) [ ] Insurance company as defined in Section 3(a)(19) of the Exchange Act. (d) [ ] Investment company registered under Section 8 of the Investment Company Act. (e) [ ] An investment adviser in accordance with Rule 13d-1(b)(1) (ii)(E). (f) [ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F}. (g) [ ] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G), (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act. (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act. (j) [ ] Group, accordance with Rule 13d-1(b)(1)(ii)(J). ITEM 4. OWNERSHIP. (a)-(b). The Filing Person beneficially owns 717,715 shares of the Common Stock of Northfield Laboratories Inc. representing 5.0 % of the outstanding shares of Common Stock. The Filing Person has sole power to vote and direct the voting of and sole power to dispose or to direct the disposition of all of the shares beneficially owned by the Filing Person. ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF CLASS. Not Applicable. ITEM 6. OWNERSHIP OF MORE THE FIVE PERCENT ON BEHALF OF ANOTHER PERSON. Not Applicable. Page 4 of 6 Pages 5 ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON. Not Applicable. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. Not Applicable. ITEM 9. NOTICE OF DISSOLUTION OF GROUP. Not Applicable. ITEM 10. CERTIFICATIONS. Not Applicable. Page 5 of 6 Pages 6 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. January 31, 2001 /s/ Richard E. DeWoskin ------------------------------------------ Richard E. DeWoskin Page 6 of 6 Pages -----END PRIVACY-ENHANCED MESSAGE-----